Gut microbiota-derived metabolites in CRC progression and causation

Abdulamir AS, Hafidh RR, Bakar FA (2010) Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8. Mol Cancer 9:249. https://doi.org/10.1186/1476-4598-9-249 Abdulamir AS, Hafidh RR, Abu Bakar F (2011) The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role. J Exp Clin Cancer Res 30:11. https://doi.org/10.1186/1756-9966-30-11 Ahn J, Sinha R, Pei Z et al (2013) Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst 105:1907–1911. https://doi.org/10.1093/jnci/djt300 Ai D, Pan H, Li X et al (2019) Identifying gut microbiota associated with colorectal cancer using a zero-inflated lognormal model. Front Microbiol. https://doi.org/10.3389/fmicb.2019.00826 Al Hinai EA, Kullamethee P, Rowland IR et al (2018) Modelling the role of microbial p-cresol in colorectal genotoxicity. Gut Microbes 10:398–411. https://doi.org/10.1080/19490976.2018.1534514 Alhinai EA, Walton GE, Commane DM (2019) The role of the gut microbiota in colorectal cancer causation. IJMS 20:5295. https://doi.org/10.3390/ijms20215295 Amarnani R, Rapose A (2017) Colon cancer and enterococcus bacteremia co-affection: a dangerous alliance. J Infect Public Health 10:681–684. https://doi.org/10.1016/j.jiph.2016.09.009 Andriamihaja M, Lan A, Beaumont M et al (2015) The deleterious metabolic and genotoxic effects of the bacterial metabolite p-cresol on colonic epithelial cells. Free Radic Biol Med 85:219–227. https://doi.org/10.1016/j.freeradbiomed.2015.04.004 Armaghany T, Wilson JD, Chu Q, Mills G (2012) Genetic alterations in colorectal cancer. Gastrointest Cancer Res 5:19–27 Bae S, Ulrich CM, Neuhouser ML et al (2014) Plasma choline metabolites and colorectal cancer risk in the Women’s health initiative observational study. Cancer Res 74:7442–7452. https://doi.org/10.1158/0008-5472.CAN-14-1835 Balamurugan R, Rajendiran E, George S et al (2008) Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J Gastroenterol Hepatol 23:1298–1303. https://doi.org/10.1111/j.1440-1746.2008.05490.x Beaumont M, Neyrinck AM, Olivares M et al (2018) The gut microbiota metabolite indole alleviates liver inflammation in mice. FASEB J. https://doi.org/10.1096/fj.201800544 Biarc J, Nguyen IS, Pini A et al (2004) Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S. bovis). Carcinogenesis 25:1477–1484. https://doi.org/10.1093/carcin/bgh091 Boleij A, van Gelder MMHJ, Swinkels DW, Tjalsma H (2011) Clinical importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis 53:870–878. https://doi.org/10.1093/cid/cir609 Boleij A, Hechenbleikner EM, Goodwin AC et al (2015) The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin Infect Dis 60:208–215. https://doi.org/10.1093/cid/ciu787 Buc E, Dubois D, Sauvanet P et al (2013) High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS ONE 8:e56964. https://doi.org/10.1371/journal.pone.0056964 Capaldo CT, Powell DN, Kalman D (2017) Layered defense: how mucus and tight junctions seal the intestinal barrier. J Mol Med 95:927–934. https://doi.org/10.1007/s00109-017-1557-x Cassidy A, Minihane A-M (2017) The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids. Am J Clin Nutr 105:10–22. https://doi.org/10.3945/ajcn.116.136051 Chakravorty A, Awad MM, Cheung JK et al (2015) The pore-forming α-toxin from Clostridium septicum activates the MAPK pathway in a Ras-c-Raf-dependent and independent manner. Toxins (basel) 7:516–534. https://doi.org/10.3390/toxins7020516 Chan CWH, Law BMH, Waye MMY et al (2019) Trimethylamine-N-oxide as one hypothetical link for the relationship between intestinal microbiota and cancer—where we are and where shall we go? J Cancer 10:5874–5882. https://doi.org/10.7150/jca.31737 Chang H, Lei L, Zhou Y et al (2018) Dietary flavonoids and the risk of colorectal cancer: an updated meta-analysis of epidemiological studies. Nutrients. https://doi.org/10.3390/nu10070950 Chen W, Liu F, Ling Z et al (2012) Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS ONE 7:e39743. https://doi.org/10.1371/journal.pone.0039743 Chen H-M, Yu Y-N, Wang J-L et al (2013) Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. Am J Clin Nutr 97:1044–1052. https://doi.org/10.3945/ajcn.112.046607 Chen J, Pitmon E, Wang K (2017) Microbiome, inflammation and colorectal cancer. Semin Immunol 32:43–53. https://doi.org/10.1016/j.smim.2017.09.006 Chen M, Zhu X, Ran L et al (2017) Trimethylamine-N-oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway. J Am Heart Assoc 6:e006347. https://doi.org/10.1161/JAHA.117.006347 Chew SS, Lubowski DZ (2001a) Clostridium septicum and malignancy. ANZ J Surg 71:647–649. https://doi.org/10.1046/j.1445-1433.2001.02231.x Cipe G, Idiz UO, Firat D, Bektasoglu H (2015) Relationship between intestinal microbiota and colorectal cancer. World J Gastrointest Oncol 7:233–240. https://doi.org/10.4251/wjgo.v7.i10.233 Cohen LJ, Kang H-S, Chu J et al (2015) Functional metagenomic discovery of bacterial effectors in the human microbiome and isolation of commendamide, a GPCR G2A/132 agonist. Proc Natl Acad Sci USA 112:E4825-4834. https://doi.org/10.1073/pnas.1508737112 Cook JW, Kennaway EL, Kennaway NM (1940) Production of tumours in mice by deoxycholic acid. Nature 145:627–627. https://doi.org/10.1038/145627a0 Corredoira J, Grau I, Garcia-Rodriguez JF et al (2017) Colorectal neoplasm in cases of Clostridium septicum and Streptococcus gallolyticus subsp. gallolyticus bacteraemia. Eur J Intern Med 41:68–73. https://doi.org/10.1016/j.ejim.2017.02.009 Cross AJ, Moore SC, Boca S et al (2014) A prospective study of serum metabolites and colorectal cancer risk. Cancer 120:3049–3057. https://doi.org/10.1002/cncr.28799 Dahmus JD, Kotler DL, Kastenberg DM, Kistler CA (2018) The gut microbiome and colorectal cancer: a review of bacterial pathogenesis. J Gastrointest Oncol 9:769–777. https://doi.org/10.21037/jgo.2018.04.07 Dai Z, Zhang J, Wu Q et al (2019) The role of microbiota in the development of colorectal cancer. Int J Cancer 145:2032–2041. https://doi.org/10.1002/ijc.32017 Dalal N, Jalandra R, Sharma M et al (2020) Omics technologies for improved diagnosis and treatment of colorectal cancer: technical advancement and major perspectives. Biomed Pharmacother 131:110648. https://doi.org/10.1016/j.biopha.2020.110648 den Besten G, van Eunen K, Groen AK et al (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54:2325–2340. https://doi.org/10.1194/jlr.R036012 Devlin AS, Marcobal A, Dodd D et al (2016) Modulation of a circulating uremic solute via rational genetic manipulation of the gut microbiota. Cell Host Microbe 20:709–715. https://doi.org/10.1016/j.chom.2016.10.021 Dieterich W, Schink M, Zopf Y (2018) Microbiota in the gastrointestinal tract. Med Sci (basel). https://doi.org/10.3390/medsci6040116 Diether NE, Willing BP (2019) Microbial fermentation of dietary protein: an important factor in diet–microbe–host interaction. Microorganisms. https://doi.org/10.3390/microorganisms7010019 Donohoe DR, Garge N, Zhang X et al (2011) The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 13:517–526. https://doi.org/10.1016/j.cmet.2011.02.018 Dziubańska-Kusibab PJ, Berger H, Battistini F et al (2020) Colibactin DNA-damage signature indicates mutational impact in colorectal cancer. Nat Med 26:1063–1069. https://doi.org/10.1038/s41591-020-0908-2 Elliott TR, Hudspith BN, Wu G et al (2013) Quantification and characterization of mucosa-associated and intracellular Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis 19:2326–2338. https://doi.org/10.1097/MIB.0b013e3182a38a92 Fan P, Li L, Rezaei A et al (2015) Metabolites of dietary protein and peptides by intestinal microbes and their impacts on gut. Curr Protein Pept Sci 16:646–654. https://doi.org/10.2174/1389203716666150630133657 Fang H, Kang J, Zhang D (2017) Microbial production of vitamin B12: a review and future perspectives. Microb Cell Fact. https://doi.org/10.1186/s12934-017-0631-y Feng Q, Chen W-D, Wang Y-D (2018) Gut microbiota: an integral moderator in health and disease. Front Microbiol 9:151. https://doi.org/10.3389/fmicb.2018.00151 Fischbach MA, Sonnenburg JL (2011) Eating for two: how metabolism establishes interspecies interactions in the gut. Cell Host Microbe 10:336–347. https://doi.org/10.1016/j.chom.2011.10.002 Forgie AJ, Fouhse JM, Willing BP (2019) Diet–microbe–host interactions that affect gut mucosal integrity and infection resistance. Front Immunol. https://doi.org/10.3389/fimmu.2019.01802 Gao Z, Guo B, Gao R et al (2015) Microbiota disbiosis is associated with colorectal cancer. Front Microbiol 6:20. https://doi.org/10.3389/fmicb.2015.00020 Gausachs M, Borras E, Chang K et al (2017) Mutational heterogeneity in APC and KRAS arises at the crypt level and leads to polyclonality in early colorectal tumorigenesis. Clin Cancer Res 23:5936–5947. https://doi.org/10.1158/1078-0432.CCR-17-0821 Georgescauld F, Mocan I, Lacombe M-L, Lascu I (2009) Rescue of the neuroblastoma mutant of the human nucleoside diphosphate kinase A/nm23-H1 by the natural osmolyte trimethylamine-N-oxide. FEBS Lett 583:820–824. https://doi.org/10.1016/j.febslet.2009.01.043 Gil-Cardoso K, Ginés I, Pinent M et al (2016) Effects of flavonoids on intestinal inflammation, barrier integrity and changes in gut microbiota during diet-induced obesity. Nutr Res Rev 29:234–248. https://doi.org/10.1017/S0954422416000159 Giovannucci E (2004) Alcohol, one-carbon metabolism, and colorectal cancer: recent insights from molecular studies. J Nutr 134:2475S-2481S. https://doi.org/10.1093/jn/134.9.2475S Goodwin AC, Destefano Shields CE, Wu S et al (2011) Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci USA 108:15354–15359. https://doi.org/10.1073/pnas.1010203108 Guertin KA, Li XS, Graubard BI et al (2017) Serum Trimethylamine N-oxide, carnitine, choline, and betaine in relation to colorectal cancer risk in the alpha tocopherol, beta carotene cancer prevention study. Cancer Epidemiol Biomark Prev 26:945–952. https://doi.org/10.1158/1055-9965.EPI-16-0948 Gur C, Ibrahim Y, Isaacson B et al (2015) Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42:344–355. https://doi.org/10.1016/j.immuni.2015.01.010 Hartwich A, Konturek S, Pierzchalski P et al (2001) Helicobacter pylori infection, gastrin, cyclooxygenase-2, and apoptosis in colorectal cancer. Int J Colorectal Dis 16:202–210. https://doi.org/10.1007/s003840100288 Howarth NC, Murphy SP, Wilkens LR et al (2008) The association of glycemic load and carbohydrate intake with colorectal cancer risk in the Multiethnic Cohort Study. Am J Clin Nutr 88:1074–1082 Huycke MM, Abrams V, Moore DR (2002) Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis 23:529–536. https://doi.org/10.1093/carcin/23.3.529 Jahani-Sherafat S, Alebouyeh M, Moghim S et al (2018) Role of gut microbiota in the pathogenesis of colorectal cancer; a review article. Gastroenterol Hepatol Bed Bench 11:101–109 Jakobsson HE, Rodríguez-Piñeiro AM, Schütte A et al (2015) The composition of the gut microbiota shapes the colon mucus barrier. EMBO Rep 16:164–177. https://doi.org/10.15252/embr.201439263 Johnson CH, Dejea CM, Edler D et al (2015) Metabolism links bacterial biofilms and colon carcinogenesis. Cell Metab 21:891–897. https://doi.org/10.1016/j.cmet.2015.04.011 Kantor ED, Lampe JW, Peters U et al (2014) Long-chain omega-3 polyunsaturated fatty acid intake and risk of colorectal cancer. Nutr Cancer 66:716–727. https://doi.org/10.1080/01635581.2013.804101 Kasai C, Sugimoto K, Moritani I et al (2016) Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: terminal restriction fragment length polymorphism and next-generation sequencing analyses. Oncol Rep 35:325–333. https://doi.org/10.3892/or.2015.4398 Kasper SH, Morell-Perez C, Wyche TP et al (2020) Colorectal cancer-associated anaerobic bacteria proliferate in tumor spheroids and alter the microenvironment. Sci Rep. https://doi.org/10.1038/s41598-020-62139-z Kato I, Boleij A, Kortman GAM et al (2013) Partial associations of dietary iron, smoking and intestinal bacteria with colorectal cancer risk. Nutr Cancer 65:169–177. https://doi.org/10.1080/01635581.2013.748922 Kennedy CL, Krejany EO, Young LF et al (2005) The alpha-toxin of Clostridium septicum is essential for virulence. Mol Microbiol 57:1357–1366. https://doi.org/10.1111/j.1365-2958.2005.04774.x Kim TJ (2017) Helicobacter pylori infection is an independent risk factor of early and advanced colorectal neoplasm—Helicobacter—Wiley Online Library. https://doi.org/10.1111/hel.12377. Accessed 18 Dec 2020 Kim K-B, Yang J-Y, Kwack SJ et al (2010) Toxicometabolomics of urinary biomarkers for human gastric cancer in a mouse model. J Toxicol Environ Health A 73:1420–1430. https://doi.org/10.1080/15287394.2010.511545 Kim E-K, Cho JH, Kim E, Kim YJ (2017) Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth. PLoS ONE 12:e0181183. https://doi.org/10.1371/journal.pone.0181183 Kim YH, Kim JH, Kim BG et al (2019) Tauroursodeoxycholic acid attenuates colitis-associated colon cancer by inhibiting nuclear factor kappaB signaling. J Gastroenterol Hepatol 34:544–551. https://doi.org/10.1111/jgh.14526 King M, Hurley H, Davidson KR et al (2020) The link between fusobacteria and colon cancer: a fulminant example and review of the evidence. Immune Netw 20:e30. https://doi.org/10.4110/in.2020.20.e30 Kishino S, Takeuchi M, Park S-B et al (2013) Polyunsaturated fatty acid saturation by gut lactic acid bacteria affecting host lipid composition. Proc Natl Acad Sci USA 110:17808–17813. https://doi.org/10.1073/pnas.1312937110 Klampfer L, Huang J, Sasazuki T et al (2003) Inhibition of interferon gamma signaling by the short chain fatty acid butyrate. Mol Cancer Res 1:855–862 Knip M, Siljander H (2016) The role of the intestinal microbiota in type 1 diabetes mellitus. Nat Rev Endocrinol 12:154–167. https://doi.org/10.1038/nrendo.2015.218 Koeth RA, Wang Z, Levison BS et al (2013) Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19:576–585. https://doi.org/10.1038/nm.3145 Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F (2016) From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165:1332–1345. https://doi.org/10.1016/j.cell.2016.05.041 Kostic AD, Gevers D, Pedamallu CS et al (2012) Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. In: Genome research. https://pubmed.ncbi.nlm.nih.gov/22009990/. Accessed 18 Sep 2020 Kostic AD, Chun E, Robertson L et al (2013) Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14:207–215. https://doi.org/10.1016/j.chom.2013.07.007 Lee DW, Han SW, Kang JK, et al (2018) Association between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in colorectal cancer. In: Annals of surgical oncology. https://pubmed.ncbi.nlm.nih.gov/30062471/. Accessed 18 Sept 2020 Levy M, Thaiss CA, Zeevi D et al (2015) Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling. Cell 163:1428–1443. https://doi.org/10.1016/j.cell.2015.10.048 Lichtenstern CR, Ngu RK, Shalapour S, Karin M (2020) Immunotherapy, inflammation and colorectal cancer. Cells. https://doi.org/10.3390/cells9030618 Liu X, Liu H, Yuan C et al (2017) Preoperative serum TMAO level is a new prognostic marker for colorectal cancer. Biomark Med 11:443–447. https://doi.org/10.2217/bmm-2016-0262 Liu T, Song X, Khan S et al (2020) The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: an old story, yet mesmerizing. Int J Cancer 146:1780–1790. https://doi.org/10.1002/ijc.32563 Long X, Wong CC, Tong L et al (2019) Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity. Nat Microbiol 4:2319–2330. https://doi.org/10.1038/s41564-019-0541-3 Lu R, Wu S, Zhang Y et al (2014) Enteric bacterial protein AvrA promotes colonic tumorigenesis and activates colonic beta-catenin signaling pathway. Oncogenesis 3:e105. https://doi.org/10.1038/oncsis.2014.20 Lu R, Wu S, Zhang Y-G et al (2016) Salmonella protein AvrA activates the STAT3 signaling pathway in colon cancer. Neoplasia 18:307–316. https://doi.org/10.1016/j.neo.2016.04.001 Lucas C, Barnich N, Nguyen HTT (2017) Microbiota, inflammation and colorectal cancer. Int J Mol Sci. https://doi.org/10.3390/ijms18061310 Lührs H, Gerke T, Müller JG et al (2002) Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol 37:458–466. https://doi.org/10.1080/003655202317316105 Lunn JC, Kuhnle G, Mai V et al (2007) The effect of haem in red and processed meat on the endogenous formation of N-nitroso compounds in the upper gastrointestinal tract. Carcinogenesis 28:685–690. https://doi.org/10.1093/carcin/bgl192 Mager LF, Burkhard R, Pett N et al (2020) Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science 369:1481–1489. https://doi.org/10.1126/science.abc3421 Maino Vieytes CA, Taha HM, Burton-Obanla AA et al (2019) Carbohydrate nutrition and the risk of cancer. Curr Nutr Rep 8:230–239. https://doi.org/10.1007/s13668-019-0264-3 Martin HM, Campbell BJ, Hart CA et al (2004) Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer. Gastroenterology 127:80–93. https://doi.org/10.1053/j.gastro.2004.03.054 Maslowski KM, Vieira AT, Ng A et al (2009) Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461:1282–1286. https://doi.org/10.1038/nature08530 McCoy AN, Araújo-Pérez F, Azcárate-Peril A et al (2013) Fusobacterium is associated with colorectal adenomas. PLoS ONE 8:e53653. https://doi.org/10.1371/journal.pone.0053653 McNabney SM, Henagan TM (2017) Short chain fatty acids in the colon and peripheral tissues: a focus on butyrate, colon cancer. Obes Insulin Resist Nutr. https://doi.org/10.3390/nu9121348 Meijnikman AS, Gerdes VE, Nieuwdorp M, Herrema H (2018) Evaluating causality of gut microbiota in obesity and diabetes in humans. Endocr Rev 39:133–153. https://doi.org/10.1210/er.2017-00192 Nam JH, Hong CW, Kim BC et al (2017) Helicobacter pylori infection is an independent risk factor for colonic adenomatous neoplasms. Cancer Causes Control 28:107–115. https://doi.org/10.1007/s10552-016-0839-x Neoptolemos JP, Clayton H, Heagerty AM et al (1988) Dietary fat in relation to fatty acid composition of red cells and adipose tissue in colorectal cancer. Br J Cancer 58:575–579. https://doi.org/10.1038/bjc.1988.262 Nougayrède J-P, Homburg S, Taieb F et al (2006) Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313:848–851. https://doi.org/10.1126/science.1127059 O’Keefe SJD (2016) Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol 13:691–706. https://doi.org/10.1038/nrgastro.2016.165 O’Keefe SJD, Li JV, Lahti L et al (2015) Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun 6:6342. https://doi.org/10.1038/ncomms7342 Ocvirk S, O’Keefe SJ (2017) Influence of bile acids on colorectal cancer risk: potential mechanisms mediated by diet–gut microbiota interactions. Curr Nutr Rep 6:315–322. https://doi.org/10.1007/s13668-017-0219-5 Ocvirk S, Wilson AS, Posma JM et al (2020) A prospective cohort analysis of gut microbial co-metabolism in Alaska Native and rural African people at high and low risk of colorectal cancer. Am J Clin Nutr 111:406–419. https://doi.org/10.1093/ajcn/nqz301 Ohira H, Tsutsui W, Fujioka Y (2017) Are short chain fatty acids in gut microbiota defensive players for inflammation and atherosclerosis? J Atheroscler Thromb 24:660–672. https://doi.org/10.5551/jat.RV17006 Oliphant K, Allen-Vercoe E (2019) Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health. Microbiome. https://doi.org/10.1186/s40168-019-0704-8 Parada Venegas D, De la Fuente MK, Landskron G et al (2019) Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. https://doi.org/10.3389/fimmu.2019.00277 Payne CM, Weber C, Crowley-Skillicorn C et al (2007) Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaB through multiple mechanisms in HCT-116 colon epithelial cells. Carcinogenesis 28:215–222. https://doi.org/10.1093/carcin/bgl139 Powolny A, Xu J, Loo G (2001) Deoxycholate induces DNA damage and apoptosis in human colon epithelial cells expressing either mutant or wild-type p53. Int J Biochem Cell Biol 33:193–203. https://doi.org/10.1016/s1357-2725(00)00080-7 Prasad KN, Bondy SC (2019) Dietary fibers and their fermented short-chain fatty acids in prevention of human diseases. Bioact Carbohydr Diet Fibre 17:100170. https://doi.org/10.1016/j.bcdf.2018.09.001 Research AA for C (2020) Colibactin causes colorectal cancer-associated mutational signature. Cancer Discov 10:635–635. https://doi.org/10.1158/2159-8290.CD-RW2020-037 Rooks MG, Garrett WS (2016) Gut microbiota, metabolites and host immunity. Nat Rev Immunol 16:341–352. https://doi.org/10.1038/nri.2016.42 Rothhammer V, Mascanfroni ID, Bunse L et al (2016) Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med 22:586–597. https://doi.org/10.1038/nm.4106 Rothhammer V, Borucki DM, Tjon EC et al (2018) Microglial control of astrocytes in response to microbial metabolites. Nature 557:724–728. https://doi.org/10.1038/s41586-018-0119-x Rowland I, Gibson G, Heinken A et al (2018) Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr 57:1–24. https://doi.org/10.1007/s00394-017-1445-8 Rubinstein MR, Wang X, Liu W et al (2013) Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14:195–206. https://doi.org/10.1016/j.chom.2013.07.012 Rubinstein MR, Baik JE, Lagana SM et al (2019) Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1. EMBO Rep. https://doi.org/10.15252/embr.201847638 Schulthess J, Pandey S, Capitani M et al (2019) The short chain fatty acid butyrate imprints an antimicrobial program in macrophages. Immunity 50:432-445.e7. https://doi.org/10.1016/j.immuni.2018.12.018 Sears CL (2001) The toxins of Bacteroides fragilis. Toxicon 39:1737–1746. https://doi.org/10.1016/s0041-0101(01)00160-x Seesaha PK, Chen X, Wu X et al (2020) The interplay between dietary factors, gut microbiome and colorectal cancer: a new era of colorectal cancer prevention. Future Oncol 16:293–306. https://doi.org/10.2217/fon-2019-0552 Shmuely H, Passaro D, Figer A et al (2001) Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol 96:3406–3410. https://doi.org/10.1111/j.1572-0241.2001.05342.x Sivaprakasam S, Prasad PD, Singh N (2016) Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. Pharmacol Ther 164:144–151. https://doi.org/10.1016/j.pharmthera.2016.04.007 Slattery ML, Potter JD, Duncan DM, Berry TD (1997) Dietary fats and colon cancer: assessment of risk associated with specific fatty acids. Int J Cancer 73:670–677. https://doi.org/10.1002/(sici)1097-0215(19971127)73:5%3c670::aid-ijc10%3e3.0.co;2-a Solé C, Guilly S, Da Silva K et al (2021) Alterations in gut microbiome in cirrhosis as assessed by quantitative metagenomics: relationship with acute-on-chronic liver failure and prognosis. Gastroenterology 160:206-218.e13. https://doi.org/10.1053/j.gastro.2020.08.054 Sun J, Kato I (2016) Gut microbiota, inflammation and colorectal cancer. Genes Dis 3:130–143. https://doi.org/10.1016/j.gendis.2016.03.004 Tatishchev SF, VanBeek C, Wang HL (2012) Helicobacter pylori infection and colorectal carcinoma: is there a causal association? J Gastrointest Oncol 3:380–385. https://doi.org/10.3978/j.issn.2078-6891.2012.058 Theodoratou E, Kyle J, Cetnarskyj R et al (2007) Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol Biomark Prev 16:684–693. https://doi.org/10.1158/1055-9965.EPI-06-0785 Thomas AM, Manghi P, Asnicar F et al (2019) Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat Med 25:667–678. https://doi.org/10.1038/s41591-019-0405-7 Tsoi H, Chu ESH, Zhang X et al (2017) Peptostreptococcus anaerobius induces intracellular cholesterol biosynthesis in colon cells to induce proliferation and causes dysplasia in mice. Gastroenterology 152:1419–1433. https://doi.org/10.1053/j.gastro.2017.01.009 (e5) Tuttolomondo A, Di Raimondo D, Pecoraro R et al (2012) Atherosclerosis as an inflammatory disease. Curr Pharm Des 18:4266–4288. https://doi.org/10.2174/138161212802481237 Vernocchi P, Del Chierico F, Putignani L (2020) Gut microbiota metabolism and interaction with food components. Int J Mol Sci 21:3688. https://doi.org/10.3390/ijms21103688 Viljoen KS, Dakshinamurthy A, Goldberg P, Blackburn JM (2015) Quantitative profiling of colorectal cancer-associated bacteria reveals associations between Fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer. PLoS ONE 10:e0119462. https://doi.org/10.1371/journal.pone.0119462 Vipperla K, O’Keefe SJ (2016) Diet, microbiota, and dysbiosis: a ‘recipe’ for colorectal cancer. Food Funct 7:1731–1740. https://doi.org/10.1039/C5FO01276G Wang Z, Zhao Y (2018) Gut microbiota derived metabolites in cardiovascular health and disease. Protein Cell 9:416–431. https://doi.org/10.1007/s13238-018-0549-0 Wang C, Ruan P, Zhao Y et al (2017) Spermidine/spermine N1-acetyltransferase regulates cell growth and metastasis via AKT/β-catenin signaling pathways in hepatocellular and colorectal carcinoma cells. Oncotarget 8:1092–1109. https://doi.org/10.18632/oncotarget.13582 Wang G, Yu Y, Wang Y-Z et al (2019) Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy. J Cell Physiol 234:17023–17049. https://doi.org/10.1002/jcp.28436 Weng Z, Patel AB, Panagiotidou S, Theoharides TC (2015) The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells. J Allergy Clin Immunol 135:1044–1052. https://doi.org/10.1016/j.jaci.2014.10.032 (e5) Wessler S, Krisch LM, Elmer DP, Aberger F (2017) From inflammation to gastric cancer—the importance of Hedgehog/GLI signaling in Helicobacter pylori-induced chronic inflammatory and neoplastic diseases. Cell Commun Signal 15:15. https://doi.org/10.1186/s12964-017-0171-4 Wilson AJ, Chueh AC, Tögel L et al (2010) Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction. Cancer Res 70:609–620. https://doi.org/10.1158/0008-5472.CAN-09-2327 Wirbel J, Pyl PT, Kartal E et al (2019) Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med 25:679–689. https://doi.org/10.1038/s41591-019-0406-6 Yachida S, Mizutani S, Shiroma H et al (2019) Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med 25:968–976. https://doi.org/10.1038/s41591-019-0458-7 Yan S, Huang J, Chen Z et al (2016) Metabolomics in gut microbiota: applications and challenges. Sci Bull 61:1151–1153. https://doi.org/10.1007/s11434-016-1142-7 Yang Y, Weng W, Peng J et al (2017) Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor-κB, and up-regulating expression of MicroRNA-21. In: Gastroenterology. https://pubmed.ncbi.nlm.nih.gov/27876571/. Accessed 18 Sept 2020 Yao L, Seaton SC, Ndousse-Fetter S et al (2018) A selective gut bacterial bile salt hydrolase alters host metabolism. Elife. https://doi.org/10.7554/eLife.37182 Ye X, Wang R, Bhattacharya R et al (2017) Fusobacterium nucleatum subspecies animalis influences proinflammatory cytokine expression and monocyte activation in human colorectal tumors. Cancer Prev Res (phila) 10:398–409. https://doi.org/10.1158/1940-6207.CAPR-16-0178 Zackular JP, Baxter NT, Iverson KD et al (2013) The gut microbiome modulates colon tumorigenesis. Mbio. https://doi.org/10.1128/mBio.00692-13 Zamani S, Taslimi R, Sarabi A et al (2019) Enterotoxigenic Bacteroides fragilis: a possible etiological candidate for bacterially-induced colorectal precancerous and cancerous lesions. Front Cell Infect Microbiol 9:449. https://doi.org/10.3389/fcimb.2019.00449 Zeng H, Umar S, Rust B et al (2019) Secondary bile acids and short chain fatty acids in the colon: a focus on colonic microbiome, cell proliferation, inflammation, and cancer. Int J Mol Sci. https://doi.org/10.3390/ijms20051214 Zhang H, Zhang A, Miao J et al (2019) Targeting regulation of tryptophan metabolism for colorectal cancer therapy: a systematic review. RSC Adv 9:3072–3080. https://doi.org/10.1039/C8RA08520J Zhou Y, He H, Xu H et al (2016) Association of oncogenic bacteria with colorectal cancer in South China. Oncotarget 7:80794–80802. https://doi.org/10.18632/oncotarget.13094